Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
- Conditions
- Clostridium Difficile
- First Posted Date
- 2007-01-04
- Last Posted Date
- 2007-01-04
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 114
- Registration Number
- NCT00417872
- Locations
- πΊπΈ
WellStar Infectious Diseases, Marietta, Georgia, United States
πΊπΈThe Reading Hospital and Medical Center, West Reading, Pennsylvania, United States
πΊπΈRemington-Davis, Inc., and Riverside Infection Consultants, Inc., Columbus, Ohio, United States
Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2007-01-04
- Last Posted Date
- 2007-01-04
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 40
- Registration Number
- NCT00418054
- Locations
- πͺπ¬
Department of Tropical Medicine & Infectious Diseases, Alexandria University, Alexandria, Egypt
πͺπ¬Department of Tropical Medicine & Infectious Diseases, Tanta University School of Medicine, Tanta, Egypt
Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2015-05-05
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 50
- Registration Number
- NCT00384527
- Locations
- πΊπΈ
Michael E. Debakey VAMC, Houston, Texas, United States
πΊπΈBay Pines VAMC, Bay Pines, Florida, United States
πΊπΈJohn D. Dingell VAMC, Ann Arbor, Michigan, United States
Study of Nitazoxanide in the Treatment of Amebiasis in Children
- Conditions
- Amebiasis
- First Posted Date
- 2006-08-21
- Last Posted Date
- 2006-08-21
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 50
- Registration Number
- NCT00366730
- Locations
- πͺπ¬
Benha University Hospital, Benha, Egypt
πͺπ¬University Hospital, Alexandria, Egypt
Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
- Conditions
- Amebiasis
- First Posted Date
- 2006-08-21
- Last Posted Date
- 2006-08-21
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 50
- Registration Number
- NCT00366236
- Locations
- πͺπ¬
Benha University Hospital, Benha, Egypt
πͺπ¬University Hospital, Alexandria, Egypt
Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
- Conditions
- Norovirus InfectionRotavirus InfectionAdenoviridae Infection
- Interventions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 50
- Registration Number
- NCT00302640
Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 98
- Registration Number
- NCT00130390
- Locations
- πΊπΈ
Gastrointestinal Associates, LLC, Kingsport, Tennessee, United States
πΊπΈNashville Medical Research, Nashville, Tennessee, United States
πΊπΈRomark Laboratories, L.C., Tampa, Florida, United States
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
- Conditions
- CryptosporidiosisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 30
- Registration Number
- NCT00004986
- Locations
- πΊπΈ
Julie Ryner, Tampa, Florida, United States
A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
- Conditions
- CryptosporidiosisHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-07-10
- Lead Sponsor
- Romark Laboratories L.C.
- Registration Number
- NCT00002158
- Locations
- πΊπΈ
Romark Laboratories LC, Tampa, Florida, United States